| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2021 | VISIONQUEST BIOMEDICAL INC | 2501 YALE BLVD SE STE 301 | ALBUQUERQUE | NM | 87106 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 8 | 11/30/2022 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = -$7,555 ) |
| 2022 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 001 | 5 | 6/29/2022 | COMPETING CONTINUATION | $0 |
| 2022 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 5 | 6/29/2022 | COMPETING CONTINUATION | -$7,555 |
|
| Issue Date FY: 2021 ( Subtotal = $1,000,000 ) |
| 2021 | 2021 | VISIONQUEST BIOMEDICAL INC | 2501 YALE BLVD SE STE 301 | ALBUQUERQUE | NM | 87106 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 8 | 11/23/2020 | NON-COMPETING CONTINUATION | $1,000,000 |
|
| Issue Date FY: 2020 ( Subtotal = $1,000,000 ) |
| 2020 | 2020 | VISIONQUEST BIOMEDICAL INC | 2501 YALE BLVD SE STE 301 | ALBUQUERQUE | NM | 87106 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 001 | 7 | 12/18/2019 | NON-COMPETING CONTINUATION | $1,000,000 |
| 2020 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 5 | 12/11/2019 | COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,000,000 ) |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 004 | 5 | 6/14/2019 | COMPETING CONTINUATION | $0 |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL INC | 2501 YALE BLVD SE STE 301 | ALBUQUERQUE | NM | 87106 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 007 | 6 | 9/11/2019 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $0 |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 002 | 5 | 5/13/2019 | COMPETING CONTINUATION | $1,485 |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 5 | 12/17/2018 | COMPETING CONTINUATION | $1,000,000 |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 005 | 5 | 9/10/2019 | COMPETING CONTINUATION | -$412,048 |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 003 | 5 | 6/12/2019 | COMPETING CONTINUATION | $0 |
| 2019 | 2019 | VISIONQUEST BIOMEDICAL INC | 2501 YALE BLVD SE STE 301 | ALBUQUERQUE | NM | 87106 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 006 | 6 | 9/10/2019 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $412,048 |
| 2019 | 2017 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 001 | 4 | 5/13/2019 | NON-COMPETING CONTINUATION | -$1,485 |
|
| Issue Date FY: 2017 ( Subtotal = $677,692 ) |
| 2017 | 2017 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 4 | 5/17/2017 | NON-COMPETING CONTINUATION | $676,207 |
| 2017 | 2016 | VISIONQUEST BIOMEDICAL LLC | 4801 LANG AVE NE STE 110 | ALBUQUERQUE | NM | 87109 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 001 | 3 | 5/18/2017 | COMPETING CONTINUATION | $1,485 |
|
| Issue Date FY: 2016 ( Subtotal = $821,709 ) |
| 2016 | 2016 | VISIONQUEST BIOMEDICAL LLC | 2501 YALE BOULEVARD SOUTHEAST | ALBUQUERQUE | NM | 87106 | BERNALILLO | USA | Allergy and Infectious Diseases Research | 000 | 3 | 5/10/2016 | COMPETING CONTINUATION | $821,709 |
|
|